fridays glp-1 Health: Weight Clinic Case Study Your comfort matters. That’s why

Nature Reviews Drug Discovery 24 , 902-903 (2025) doi: Competing Interests The authors declare no competing interests.

Dr Hamdy is enthusiastic about the pharma industry's investment in new products, and the growing insight into its pathophysiology

Trouble wearing contact lenses or driving at night

Device In the US, Wegovy is available as single-dose autoinjector for both reimbursed and self-pay users, while Zepbound offers vials for self-pay and higher-priced autoinjectors for reimbursed segments

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly

Effect of retatrutide on kidney parameters in people with type 2 diabetes and/or obesitya post-hoc analysis of two phase 2 trials